ARTICLE | Clinical News
OvaRex MAb: Completed Phase II/IIb trial
September 10, 2001 7:00 AM UTC
AltaRex Corp. (TSE:AXO; ALXFF), Waltham, Mass. Product: OvaRex MAb Business: Cancer Therapeutic category: Immune stimulation, Antibody Target: CA125 Description: Murine monoclonal antibody (MAb) aga...